GrantQuick

health · HHS-NIH11

Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed)

National Institutes of Health · PAR-27-049

Closed

Deadline

TBD

GRANTQUICK SUMMARYPlain-English Overview

Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed). National Institutes of Health. This Notice of Funding Opportunity (NOFO) solicits applications that propose to conduct time-sensitive ancillary studies in conjunction with privately or publicly funded, active, ongoing clinical projects (parent projects). The parent project can be an interventional clinical trial, or a... Funding amounts not specified.

Who Should Apply

Federally Recognized Native American Tribal Governments, Independent school districts, Private universities/colleges, Special district governments, Public universities/colleges (+10 more)

Who Should NOT Apply

Organizations not matching the eligible applicant types listed above

Key Requirements (Plain English)

  • Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U

💡 GrantQuick Tip

Focus your proposal on clear outcomes, alignment with agency priorities, and demonstrate organizational capacity.

Competitiveness: Moderate to high — federal grants are always competitive

What This Grant Funds

This Notice of Funding Opportunity (NOFO) solicits applications that propose to conduct time-sensitive ancillary studies in conjunction with privately or publicly funded, active, ongoing clinical projects (parent projects). The parent project can be an interventional clinical trial, or a clinical study such as an observational study, or a disease-specific repository that will be actively collecting patient samples or clinical data. The parent project(s) should provide a cohort of well-characterized patients, infrastructure, data, and biological samples for the ancillary study. The objective of this NOFO is to provide a flexible mechanism to leverage currently funded resources and maximize the return on existing investments in parent projects. Successful ancillary studies will enhance the scientific content and value of the parent projects, improve the research community’s understanding of a disease or organ system and thus may identify novel targets for diagnosis, treatment, and prevention of disease.

Who Can Apply

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

Eligible Applicant Types

Federally Recognized Tribal GovernmentsIndependent School DistrictsPrivate Colleges & UniversitiesSpecial District GovernmentsPublic Colleges & UniversitiesOther Tribal OrganizationsFor-Profit OrganizationsState GovernmentsCounty GovernmentsSmall Businesses501(c)(3) NonprofitsCity/Township GovernmentsNonprofits without 501(c)(3)Other (see NOFO for details)Public And Indian Housing Authorities

Funding Details

Cost Sharing Required?
No
Funding Instrument
grant

Key Dates

Posted: June 12, 2025
Application Deadline: TBD (0 days remaining)

Agency Contact

National Institute of Arthritis and Musculoskeletal and Skin Diseases Please contact via e-mail.

AncillaryStudies@nih.gov

Ready to apply?

View the full NOFO and submit your application on Grants.gov